Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

Human skin equivalent approved in Canada

April 8, 1997

Clinical efficacy and safety of Aphthasol reviewed

April 7, 1997

Court rules in favor of Novopharm regarding generic ranitidine product

April 7, 1997

FDA clears Faulding's generic captopril

April 7, 1997

Shire's sustained-release carbamazepine deemed approvable by FDA

April 4, 1997

Budesonide cleared in Canada for Crohn's disease

April 4, 1997

Digital Gene Technologies and Recordati collaborate on atherosclerosis research

April 4, 1997

New indication for liquid Nutropin approved by FDA

April 4, 1997

New epilepsy option approved in the U.S.

April 2, 1997

FDA tentatively approves generic acyclovir

April 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
IMV-101 shows promise for B-cell malignancies
BioWorld Science
IMV-101 is a new CAR T-cell therapy targeting CD19 developed by Suzhou Immunofoco Biotechnology Co. Ltd. for the potential treatment of B-cell malignancies and...